BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24532706)

  • 1. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis.
    Pandurangan AK; Dharmalingam P; Sadagopan SK; Ganapasam S
    Hum Exp Toxicol; 2014 Nov; 33(11):1176-85. PubMed ID: 24532706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis.
    Ashokkumar P; Sudhandiran G
    Biomed Pharmacother; 2008 Nov; 62(9):590-7. PubMed ID: 18692983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice.
    Pandurangan AK; Dharmalingam P; Ananda Sadagopan SK; Ganapasam S
    Asian Pac J Cancer Prev; 2012; 13(4):1569-73. PubMed ID: 22799368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway.
    Ashokkumar P; Sudhandiran G
    Invest New Drugs; 2011 Apr; 29(2):273-84. PubMed ID: 20013030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin, a bioflavonoid, attenuates azoxymethane-induced effects on mitochondrial enzymes in BALB/c mice.
    Pandurangan AK; Ananda Sadagopan SK; Dharmalingam P; Ganapasam S
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6669-72. PubMed ID: 24377586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical imaging of MMP expression and cancer progression in an inflammation-induced colon cancer model.
    Lee CM; Jang D; Cheong SJ; Jeong MH; Kim EM; Kim DW; Lim ST; Sohn MH; Jeong HJ
    Int J Cancer; 2012 Oct; 131(8):1846-53. PubMed ID: 22287125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soybean saponin inhibits tumor cell metastasis by modulating expressions of MMP-2, MMP-9 and TIMP- 2.
    Kang JH; Han IH; Sung MK; Yoo H; Kim YG; Kim JS; Kawada T; Yu R
    Cancer Lett; 2008 Mar; 261(1):84-92. PubMed ID: 18086515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2.
    Pandurangan AK; Kumar SA; Dharmalingam P; Ganapasam S
    Pharmacogn Mag; 2014 Apr; 10(Suppl 2):S306-10. PubMed ID: 24991108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
    Yao X; Jiang W; Yu D; Yan Z
    Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through activation of Nrf2 signaling.
    Pandurangan AK; Ananda Sadagopan SK; Dharmalingam P; Ganapasam S
    Toxicol Mech Methods; 2014 Jan; 24(1):13-20. PubMed ID: 24024667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of disequilibrium of expression of matrix metalloproteinase-2/9 and their tissue inhibitors in pathogenesis of hyperoxia-induced acute lung injury in mice].
    Zhang XF; Zhu GF; Liu S; Foda HD
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Oct; 20(10):597-600. PubMed ID: 18926070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
    Tanaka T; Kojima T; Suzui M; Mori H
    Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MT1-MMP and TIMP-2 are first expressed in the colon glands after a single dose of azoxymethane (AOM).
    da Silva J; Freitas JR; do Carmo ER; Gomes JR
    Anat Rec (Hoboken); 2024 Jun; 307(6):2187-2196. PubMed ID: 37966140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The matrix metalloproteinase inhibitor marimastat promotes neural progenitor cell differentiation into neurons by gelatinase-independent TIMP-2-dependent mechanisms.
    Sinno M; Biagioni S; Ajmone-Cat MA; Pafumi I; Caramanica P; Medda V; Tonti G; Minghetti L; Mannello F; Cacci E
    Stem Cells Dev; 2013 Feb; 22(3):345-58. PubMed ID: 23098139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.